Vanta Bioscience Limited Share Price

Vanta Bioscience Limited Share Price

BSE: 540729
|
Diversified
|
S Cap
₹ 19.64
+0.00 (0.00%)
1D
Last updated 13 Aug, 2026, 09:57 IST
--
0.00% up today
--
1D LOW
1D HIGH

Vanta Bioscience Limited Returns Calculator

Circuit
L
H
₹18.66
₹20.62
52-week
L
H
₹14.71
₹29.00

About Vanta Bioscience Limited

Vanta Bioscience Limited Share Price
ISIN
INE695X01011
Sector Market Cap
₹ 13.96 Cr

Vanta Bioscience Limited is an India-based preclinical contract research company. The Company provides services for testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers a host of preclinical safety assessment services for clients from pharmaceuticals, medical devices, nutraceuticals, feed additives, biotech, agrochemicals, cosmetics, and chemical industries. Additionally, it provides risk assessment services to evaluate the safety of active pharmaceutical ingredients, excipients, extractables, leachable, and pharmaceutical impurities resulting from the manufacturing process or product degradation. The Company’s services include discovery toxicology, agro-chemical and chemical safety, biocompatibility studies, diet formulation, and batch release tests. The Company has investments in one of its subsidiaries, Vantaclinical Research Limited.

Vanta Bioscience Limited Financial Highlights

  • Revenue: Vanta Bioscience Limited reported revenue of ₹1.98 crore in FY26 vs ₹1.17 crore in FY25. It showed an increase of 69.23% on a yearly basis.
  • Operating Profit: Vanta Bioscience Limited reported an operating profit of ₹0.01 crore in FY26 vs ₹2.73 crore in FY25. It showed an increase of 100.37% on a year-on-year basis.
  • Net Profit: Vanta Bioscience Limited reported a net profit of ₹0.11 crore in FY26 vs ₹2.67 crore in FY25. It showed an increase of 104.12% on a yearly basis.
Know more
Promoters
72.81%
FII
0.00%
Other DII
0.00%
Retail and other
27.19%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20250.00%
Jun 20250.00%
Sep 20250.00%
Mar 20260.00%
Mkt Cap Cr
13.96
P/E
—
P/B
—
ROE
—
D/E
0.00
ROCE
—
Div. Yield
0.00%
EPS(TTM)
0.17
Turnover
0.03
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
0.00
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Vanta Bioscience has not beaten FD return of 7%
Step 3 of 5
Earnings
Neutral
Vanta Bioscience earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,26,300.0058.1513.3220.48%0.3217.27%692.920.23%0.66103.81
Max Healthcare96,763.1066.419.0113.42%0.0912.97%91.840.20%0.277.37
MANIPAL HEALTH ENTERPRI L95,496.40105.375.8110.59%0.469.51%0.000.00%0.000.00
Fortis Healthcare68,901.3064.366.9610.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare68,591.90189.1614.978.48%0.3110.10%53.530.23%0.435.20
Narayana Hrudayalaya38,439.2047.078.4717.76%0.7611.42%127.100.24%0.7624.77
Global Health38,148.9069.089.6314.05%0.0615.26%149.240.04%0.7318.46
Dr. Lal Path Labs32,258.9059.0412.8620.13%0.0825.56%147.341.06%0.9130.45
KRISHNA INST OF MED SCI L32,231.30165.758.6010.74%0.637.99%93.540.00%0.426.52
Poly Medicure17,930.3057.305.7710.37%0.0812.71%301.170.20%0.4833.15

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Vanta Bioscience Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1.96₹9.72₹6.28₹9.69
Other Income₹0.11₹0.11₹0.69₹0.42
Total Revenue₹2.07₹9.83₹6.96₹10.11
Total Expenses₹14.70₹18.66₹17.23₹9.88
Profit Before Tax-₹12.63-₹8.83-₹10.26₹0.23
Tax₹0.66-₹0.22₹0.18₹0.09
Profit After Tax-₹13.29-₹8.61-₹10.44₹0.13
EPS - Basic-₹7.56-₹3.67-₹10.27₹0.14
EPS - Diluted-₹7.56-₹3.67-₹10.27₹0.14

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Profit before tax-₹8.83-₹10.26₹0.23₹0.59
Income before WC changes₹1.38-₹1.71₹3.89₹3.96
Change in Assets-₹1.76-₹0.21₹1.69₹2.46
Change in Liabilities₹3.07₹1.29-₹0.30₹0.55
Change in WC₹1.31₹1.08₹1.39₹3.01
Cash flow from Operations₹2.68-₹0.63₹5.28₹6.97
Cash flow from Investing-₹3.31-₹5.91-₹17.18-₹22.19
Cash flow from Financing₹0.69₹6.41₹9.53₹17.78
Total Cash Flow₹0.06-₹0.13-₹2.43₹2.46
Cash (Start of the year)₹0.10₹0.22₹2.65₹0.20
Cash (End of the year)₹0.16₹0.10₹0.22₹2.65

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹70.52₹68.24₹69.47₹66.91
Current Assets₹15.36₹17.16₹15.24₹14.50
Total Assets₹85.88₹85.40₹84.71₹81.40
Current Liabilities₹26.56₹22.79₹17.75₹17.76
Net Current Asset-₹11.21-₹5.62-₹2.50-₹3.26
Non-Current Liabilities₹55.53₹49.64₹48.03₹34.30
Equity Capital₹3.78₹12.97₹18.93₹29.34
Total Equity & Liabilities₹85.88₹85.40₹84.71₹81.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1.13₹8.56₹5.17₹9.35
Other Income₹0.04₹0.05₹0.63₹0.17
Total Revenue₹1.17₹8.61₹5.80₹9.52
Total Expenses₹3.89₹8.56₹10.00₹9.38
Profit Before Tax-₹2.72₹0.04-₹4.21₹0.14
Tax-₹0.06-₹0.01₹0.03₹0.06
Profit After Tax-₹2.66₹0.05-₹4.24₹0.08
EPS - Basic-₹4.21₹0.08-₹6.71₹0.12
EPS - Diluted-₹4.21₹0.08-₹6.71₹0.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Profit before tax₹0.04-₹4.21₹0.14₹0.61
Income before WC changes₹3.66₹0.15₹3.57₹3.89
Change in Assets-₹0.72₹0.03₹2.61₹4.04
Change in Liabilities₹1.61₹0.47₹0.52₹3.07
Change in WC₹0.89₹0.49₹3.13₹7.11
Cash flow from Operations₹4.55₹0.64₹6.70₹11.01
Cash flow from Investing-₹1.67-₹2.53-₹8.05-₹9.86
Cash flow from Financing-₹2.81₹1.88₹1.38-₹1.07
Total Cash Flow₹0.07₹0.00₹0.00-₹0.02
Cash (Start of the year)₹0.07₹0.07₹0.07₹0.09
Cash (End of the year)₹0.14₹0.07₹0.07₹0.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹45.44₹40.88₹40.51₹39.40
Current Assets₹10.39₹12.03₹11.13₹11.00
Total Assets₹55.84₹52.91₹51.64₹50.40
Current Liabilities₹18.57₹14.20₹10.25₹9.98
Net Current Asset-₹8.18-₹2.18₹0.89₹1.02
Non-Current Liabilities₹20.13₹18.91₹21.65₹16.43
Equity Capital₹17.13₹19.79₹19.74₹23.99
Total Equity & Liabilities₹55.84₹52.91₹51.64₹50.40
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
2
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
36.16
Neutral
ATR (14)
0.86
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
28.93
Bearish
UO(9)
17.52
Bullish
ROC(12)
-20.55
Bearish
WillR(14)
-100
Bullish
Period
Simple value
Exponential vaue
5D
21.54
21.37
10D
23.17
22.37
20D
23.33
22.57
50D
20.25
21.51
100D
21.15
20.25

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Vanta Bioscience Limited Share Price
Vanta Bioscience Limited
Diversified
Add Stock
Add Another

Vanta Bioscience Limited Share Price FAQs

Vanta Bioscience Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837